Literature DB >> 9703541

Use of statins. Sheffield table is useful.

L E Ramsay, E J Wallis, I U Haq, R Williamson, W W Yeo, P R Jackson.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9703541      PMCID： PMC1113724          DOI： 10.1136/bmj.317.7156.473a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia. Dyslipidaemia Advisory Group on behalf of the scientific committee of the National Heart Foundation of New Zealand.

Authors: 
Journal:  N Z Med J       Date:  1996-06-28

2.  The emerging role of statins in the prevention of coronary heart disease.

Authors:  M F Muldoon; M H Criqui
Journal:  BMJ       Date:  1997-12-13

Review 3.  Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.

Authors:  K Pyörälä; G De Backer; I Graham; P Poole-Wilson; D Wood
Journal:  Eur Heart J       Date:  1994-10       Impact factor: 29.983

4.  Lipid-lowering for prevention of coronary heart disease: what policy now?

Authors:  I Ul Haq; L E Ramsay; D M Pickin; W W Yeo; P R Jackson; J N Payne
Journal:  Clin Sci (Lond)       Date:  1996-10       Impact factor: 6.124

5.  Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease.

Authors:  I U Haq; P R Jackson; W W Yeo; L E Ramsay
Journal:  Lancet       Date:  1995-12-02       Impact factor: 79.321
  5 in total
  1 in total

1.  Cholesterol: how low is low enough? Effect of a given concentration depends on several factors.

Authors:  A R Walker
Journal:  BMJ       Date:  1999-02-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.